Default: Pharmacogenetics and Genomics

ISSN: 1744-6872

Journal Home

Journal Guideline

Pharmacogenetics and Genomics Q3 Unclaimed

Lippincott Williams and Wilkins Ltd. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacogenetics and Genomics is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 139. It has an SJR impact factor of 0,774 and it has a best quartile of Q3. It is published in English.

Pharmacogenetics and Genomics focuses its scope in these topics and keywords: cypa, genes, variation, cypc, nicotine, european, variants, therapy, pathway, response, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


Pharmacogenetics and Genomics


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Aims and Scope

cypa, genes, variation, cypc, nicotine, european, variants, therapy, pathway, response, glucuronidation, risk, asthma, common, levels, adverse, alleles, genetic, ugtb, contribution, influence, polymorphisms,

Best articles

A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure

View more

A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout

View more

A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

View more

A pharmacogene database enhanced by the 1000 Genomes Project

View more

A possible association of the norepinephrine transporter gene in the development of heroin dependence in Han Chinese

View more

A systematic analysis and comparison of warfarin initiation strategies

View more

Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy

View more

ADH4 intronic variations are associated with alcohol dependence

View more

Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease

View more

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients

View more

Association between TAAR6 polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients

View more

Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men

View more

Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals

View more

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene.

View more

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

View more

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

View more

Codeine and morphine pathway

View more

Comment on Xie et al.

View more

Comprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity

View more

CYP1A21*F contains the -163C >A substitution and is highly inducible

View more

CYP1A21*F contains the -163C>A substitution and is highly inducible

View more

CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers

View more

CYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects

View more

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population

View more


No comments ... Be the first to comment!